1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics, September 2015 (p30)

Therapy Analysis & Statistics, September 2015 (p30)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

871-900 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

Kidney Cancer Treatment Drugs  Industry Forecasts - China Focus

Kidney Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • September 2015
  • by Asia Market Information & Development Company

This study focuses on China’s Kidney Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

  • Industries : Pharmaceutical, Drug and Medication, Pathology, General Medicine and Specialty Medicine
  • Countries : China
Skin Cancer Treatment Drugs  Industry Forecasts - China Focus

Skin Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • September 2015
  • by Asia Market Information & Development Company

This study focuses on China’s Skin Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, Biological Therapy
  • Countries : China
United Therapeutics Corporation (UTHR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

United Therapeutics Corporation (UTHR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2015
  • by Global Data

Summary United Therapeutics Corporation (UTC) is a biotechnology company. It develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary ...

  • Industries : Therapy
Opexa Therapeutics, Inc. (OPXA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Opexa Therapeutics, Inc. (OPXA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2015
  • by Global Data

Summary Opexa Therapeutics, Inc. (Opexa) formerly PharmaFrontiers and Opexa Pharmaceuticals, is a biotechnology company that develops autologous cellular therapies for the treatment of sclerosis, rheumatoid ...

  • Industries : Therapy
Regulus Therapeutics Inc. (RGLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Regulus Therapeutics Inc. (RGLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2015
  • by Global Data

Summary Regulus Therapeutics Inc. (Regulus Therapeutics) is a biopharmaceutical company that discovers, develops and commercializes microRNA based therapeutics. The company develops single stranded ol ...

  • Industries : Therapy
  • Countries : United States
Novita Therapeutics, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Novita Therapeutics, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2015
  • by Global Data

Summary Novita Therapeutics, LLC (Novita) is a biopharmaceutical and medical device company. It undertakes development of innovative new drugs and medical devices through spinout process. The company’s ...

  • Industries : Therapy
Revance Therapeutics, Inc. (RVNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Revance Therapeutics, Inc. (RVNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2015
  • by Global Data

Summary Revance Therapeutics, Inc. (Revance) is a bio-pharmaceutical company that develops, manufactures and commercializes novel botulinum toxin products for multiple aesthetic and therapeutic applications. ...

  • Industries : Therapy
Ocata Therapeutics, Inc. (OCAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ocata Therapeutics, Inc. (OCAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2015
  • by Global Data

Summary Ocata Therapeutics, Inc. (Ocata) formerly known as Advanced Cell Technology, Inc. is a clinical stage biotechnology company that specializes in regenerative medicine. The company develops and commercializes ...

  • Industries : Therapy
Nuo Therapeutics, Inc. (NUOT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nuo Therapeutics, Inc. (NUOT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2015
  • by Global Data

Summary Nuo Therapeutics, Inc. (Nuo Therapeutics) is a biomedical company, which specializes in leading-edge biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, ...

  • Industries : Therapy
Tenax Therapeutics, Inc. (TENX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tenax Therapeutics, Inc. (TENX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2015
  • by Global Data

Summary Tenax Therapeutics, Inc. formerly Oxygen Biotherapeutics, Inc. develops medical and cosmetic products that efficiently deliver oxygen to tissues in the body. The company is currently developing ...

  • Industries : Therapy
  • Countries : United States
Cystinosis Global Clinical Trials Review, H2, 2015

Cystinosis Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Cystinosis Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H2, 2015" provides an overview of Cystinosis clinical trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : World
Nephropathy Global Clinical Trials Review, H2, 2015

Nephropathy Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Nephropathy Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Nephropathy Global Clinical Trials Review, H2, 2015" provides an overview of Nephropathy clinical trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Microalbuminuria Global Clinical Trials Review, H2, 2015

Microalbuminuria Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Microalbuminuria Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Microalbuminuria Global Clinical Trials Review, H2, 2015" provides an overview of Microalbuminuria ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015

Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Kidney Disease Global Clinical Trials Review, H2, 2015

Kidney Disease Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Kidney Disease Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview of Kidney Disease clinical ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy
  • Countries : World
Proteinuria Global Clinical Trials Review, H2, 2015

Proteinuria Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Proteinuria Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Proteinuria Global Clinical Trials Review, H2, 2015" provides an overview of Proteinuria clinical trials ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy
  • Countries : World
Nephrotic Syndrome Global Clinical Trials Review, H2, 2015

Nephrotic Syndrome Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Nephrotic Syndrome Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Nephrotic Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Nephrotic Syndrome ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy, Pathology
  • Countries : World
Renal Failure Global Clinical Trials Review, H2, 2015

Renal Failure Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Renal Failure Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2015" provides an overview of Renal Failure clinical ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : World
Renal Stones/Calculi Global Clinical Trials Review, H2, 2015

Renal Stones/Calculi Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Renal Stones/Calculi Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H2, 2015" provides an overview of Renal Stones/Calculi ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Renal Insufficiency Global Clinical Trials Review, H2, 2015

Renal Insufficiency Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Renal Insufficiency Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Renal Insufficiency Global Clinical Trials Review, H2, 2015" provides an overview of Renal Insufficiency ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy, Pathology
  • Countries : World
Glomerulonephritis Global Clinical Trials Review, H2, 2015

Glomerulonephritis Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Glomerulonephritis Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Glomerulonephritis Global Clinical Trials Review, H2, 2015" provides an overview of Glomerulonephritis ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy, Pathology
  • Countries : World
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2024

  • $ 10 995
  • Industry report
  • September 2015
  • by Global Data

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2024 Summary Multiple Sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system which leads to neurological ...

  • Industries : Hospitality, Hospitality, Biopharmaceutical, Tourism, Tourism, Biotechnology, Pharmaceutical
  • Countries : World, Asia
Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Industry report
  • September 2015
  • by Global Data

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Hypogonadotropic Hypogonadism - Pipeline Review, H2 2015

Hypogonadotropic Hypogonadism - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • September 2015
  • by Global Markets Direct

Hypogonadotropic Hypogonadism - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Hypogonadotropic Hypogonadism - Pipeline Review, H2 2015’, provides an overview of the Hypogonadotropic ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : United States
Polycythemia Vera - Pipeline Review, H2 2015

Polycythemia Vera - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • September 2015
  • by Global Markets Direct

Polycythemia Vera - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H2 2015’, provides an overview of the Polycythemia Vera’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Anchor Therapeutics, Inc. - Product Pipeline Review - 2015

Anchor Therapeutics, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • September 2015
  • by Global Markets Direct

Anchor Therapeutics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Anchor Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Anchor Therapeutics, ...

  • Industries : Therapy, Research and Development, Pharmaceutical
  • Countries : World
Vulvovaginal Candidiasis - Pipeline Review, H2 2015

Vulvovaginal Candidiasis - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • September 2015
  • by Global Markets Direct

Vulvovaginal Candidiasis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Vulvovaginal Candidiasis - Pipeline Review, H2 2015’, provides an overview of the Vulvovaginal Candidiasis’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2015

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • September 2015
  • by Global Markets Direct

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Acute Lymphoblastic ...

  • Industries : Pathology
  • Countries : United States
Global Cervical Cancer Market 2015-2019

Global Cervical Cancer Market 2015-2019

  • $ 2 500
  • Industry report
  • September 2015
  • by Infiniti Research Limited

About cervical cancer Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified ...

  • Industries : Pharmaceutical, Pathology, Drug and Medication, Biopharmaceutical, Therapy
  • Countries : World, United States
About 800 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • January 2016
    178 pages
  • Cancer  

    Rituximab  

    Oncology  

  • United Kingdom  

View report >

Us - Country Risk

December 2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.